Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led research team has found a way to counter this challenge by pairing two antibodies — one that anchors to a stable part of the virus and another that blocks infection. This innovative approach has successfully neutralized all tested SARS-CoV-2 [...]from SciTechDaily https://ift.tt/gOmD0q1
